To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
49 Current news of Carl Zeissrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
ZEISS plans to expand its market presence in Poland for its Industrial Quality & Research segment by acquiring LENSO. The company will become part of ZEISS Industrial Quality Solutions. Headquartered in Poznan, Poland, LENSO is the leading partner in Poland for 3D optical systems. With this ...
Significant revenue growth of 8.8 billion euros despite challenging geopolitical and economic conditions
The ZEISS Group achieved significant growth across all segments despite challenging geopolitical and economic conditions. Revenue rose by 16% to 8.8 billion euros, surpassing over 8 billion euros for the first time (prior year: 7.5 billion euros) in fiscal year 2021/22 (end of reporting period: ...
Positive trend continues despite challenging conditions
The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year: revenue increased by 20% to 4.1 billion euros (prior year: 3.4 billion ...
In fiscal year 2020/21, ZEISS achieves highest revenue yet in its 175-year history at 7.5 billion euros
The ZEISS Group ended fiscal year 2020/21 (end of reporting period: 30 September 2021) on an excellent note: its revenue rose by 20% to 7.529 billion euros (previous year: 6.297 billion euros). Over 90% of this sum was generated in markets outside Germany. Earnings before interest and tax (EBIT) ...
Dr. Ludwin Monz will be stepping down from his position as President and CEO of the Executive Board of Carl Zeiss Meditec AG at his own request
President and CEO of Carl Zeiss Meditec AG, Dr. Ludwin Monz, has announced to the Supervisory Board that he will not be accepting another term in office. The Supervisory Board notes his decision with regret. Dr. Monz and the Supervisory Board have agreed to end his term on 31 December 2021. Dr. ...
ZEISS Group successfully navigates pandemic thanks to broad portfolio and global structure
The ZEISS Group had a successful end to the first six months of fiscal year 2020/21 (ended 31 March 2021). It saw its revenue rise by 6 percent (adjusted for currency fluctuations, by 9 percent) to 3.406 billion euros (previous year: 3.213 billion euros). Around 90% of this sum was generated in ...
BOSELLO HIGH TECHNOLOGY becomes Carl Zeiss X-ray Technologies Srl
ZEISS and BOSELLO HIGH TECHNOLOGY (BOSELLO) announce that the Italian supplier of solutions for industrial X-ray systems, is now fully part of the ZEISS Group and will operate under the name Carl Zeiss X-ray Technologies Srl. In 2018, ZEISS acquired a majority stake in BOSELLO to strengthen its ...
Revenue increases by 11 percent to 6.4 billion euros
The ZEISS Group continued its growth trajectory, with revenue and earnings reaching new heights in fiscal year 2018/19, which ended 30 September 2019. Revenue grew by 11 percent, reaching 6.428 billion euros (previous year: 5.817 billion euros). Adjusted for currency and acquisition effects ...
Development of small and cost-effective sensors for industrial use
ZEISS’ investment in Senorics marks the start of a technology collaboration with the sensorics startup based in Dresden, Germany. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. on ...
At its meeting on 24 September 2019, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a Member of the Executive Board, will become the new President & CEO effective 1 April 2020. With this appointment, ...